Clinical Trials Sponsored by MICALIS Institute

Total 74555 results

National Cancer Institute (NCI)

Completed

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Kaposi's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Family Study of Melanoma in Italy

Melanoma | Dysplastic Nevi | Melanocytic Nevi

Spain, Italy
National Cancer Institute (NCI)

Completed

Molecular Epidemiology of Cutaneous Malignant Melanoma

Melanoma

United States
National Eye Institute (NEI)

Completed

Sirolimus Injections for Autoimmune Scleritis (ISAS)

Scleritis

United States
National Cancer Institute (NCI)

Completed

Follow-Up Study of Kidney Cancer Patients

Renal Cancer

Czechia, Poland
National Cancer Institute (NCI)

Completed

Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site

BMI | General Demographics Characteristics

Costa Rica
National Cancer Institute (NCI)

Terminated

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Neoplasms

China
National Cancer Institute (NCI)

Completed

Early Detection of Barrett's Esophagus

Barrett's Esophagus

United States
National Cancer Institute (NCI)

Completed

Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study

Prostate

United States, China
National Cancer Institute (NCI)

Terminated

NCI UNC Project ESCC

Esophageal Squamous Cell Carcinoma

Malawi
National Cancer Institute (NCI)

Completed

DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer

Lung Neoplasms

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

Normal Donors

United States
National Cancer Institute (NCI)

Completed

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Plexiform Neurofibromas | NF1

United States
National Cancer Institute (NCI)

Completed

Breast Cancer, Breast Disease, and Pesticides

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Studying Normal Breast Tissue and Cancer Risk

Neoplasms | Skin Diseases | Neoplasms by Site | Breast Neoplasms | Breast Diseases

United States
National Cancer Institute (NCI)

Completed

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Cancer | Organ Transplantation | Immunocompromised Host

United States
National Cancer Institute (NCI)

Completed

Early Life Exposures in Agriculture

Lymphoma | Leukemia | Brain Cancer | Testicular Cancer

United States
National Cancer Institute (NCI)

Completed

Premenopausal Hormone Concentrations in a Population of Women at Very Low Risk of Breast Cancer

Menopause | Normal Physiology

Mongolia
National Cancer Institute (NCI)

Completed

Cancer Risk in X-Ray Technologists: Second Survey

Radiation-Induced Neoplasms | Breast+Neoplasm+Radiation+Etiology | Thyroid+Neoplasm+Radiation+Etiology

United States
National Cancer Institute (NCI)

Completed

Bone Mineral Density and Subsequent Cancer Risk

Breast Cancer | Endometrial Cancer

United States
National Cancer Institute (NCI)

Withdrawn

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

United States
National Cancer Institute (NCI)

Completed

Cervical Cancer Early Endpoints and Determinants

Cervical Cancer | CIN | Neoplasia | Cervical Intraepithelial

United States
National Cancer Institute (NCI)

Completed

Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC

MDS | Immunodeficiency | GATA2

United States
Yale University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Texting to Promote Tobacco Abstinence in Emergency Department Smokers: A Pilot Study

Smoking | Tobacco Abstinence

United States
National Cancer Institute (NCI)

Completed

Diet and Nutrition Pilot Study for Chinese Adolescents and Their Mothers

Physical Activity | Body Composition | Puberty | Methylation

China
National Cancer Institute (NCI)

Terminated

Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas

Sarcoma | Esophageal Cancer | Thymic Carcinoma | Lung Cancer | Malignant Pleural Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Recontacting Participants in the Observing Protein and Energy Nutrition (OPEN) Study: Re-OPEN

Diet | Diet Surveys

United States
National Cancer Institute (NCI)

Completed

Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident

Leukemia

Ukraine
National Cancer Institute (NCI)

Terminated

Von Hippel-Lindau Disease Genetic Epidemiology Study

Kidney Neoplasms | Von Hippel Lindau Disease

United States
National Cancer Institute (NCI)

Completed

A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)

Breast Neoplasms | Head and Neck Neoplasms | Lung Neoplasms | Urinary Bladder Neoplasms

United States
National Cancer Institute (NCI)

Completed

AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer

Colon Cancer | Colonic Neoplasms | Colonic Cancer | Cancer of the Colon | Colon Neoplasms

United States
National Cancer Institute (NCI)

Terminated

Amatuximab for High Mesothelin Cancers

Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Mesothelioma | Carcinoma, Pancreatic Ductal

United States
National Cancer Institute (NCI)

Terminated

A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Breast Cancer | Lung Cancer | Renal Cancer | Adrenal Cancer

United States
National Cancer Institute (NCI)

Terminated

Relationship of Genetic Differences to the Development of Chromosome Abnormalities

Radiation Exposure

Russian Federation
National Cancer Institute (NCI)

Completed

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

Solid Tumors

United States
National Eye Institute (NEI)

Completed

Analyses of Existing Framingham Data

Eye Diseases

United States
National Cancer Institute (NCI)

Terminated

-02341066 and PF-00299804 for Advanced Non-Small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Squamous Cell | Carcinoma, Non-Small Cell Lung | Carcinoma, Large Cell

United States
National Cancer Institute (NCI)

Completed

Feasibility Study of a Web-Based Automated Self-Administered 24-hour Dietary Recall (ASA 24) and a Physical Activity 24-hour Recall

Cancer

United States
National Cancer Institute (NCI)

Completed

ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Withdrawn

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

Metastatic Thyroid Cancer
National Cancer Institute (NCI)

Withdrawn

Feasibility of Identifying a Chinese Study Population and Eligible Pediatric Cancer Cases, and Linking the Two Groups to Assess the Role of Periconceptional Folic Acid Supplements in Risk of Pediatric Cancer.

Pediatric Leukemia | Pediatric Brain Neoplasms | Other Pediatric Cancers
National Cancer Institute (NCI)

Withdrawn

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Multiple Myeloma
National Eye Institute (NEI)

Completed

Evaluation and Treatment of People With Eye Diseases

Eye Diseases

United States
National Cancer Institute (NCI)

Completed

Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development

Cancer

United States
National Cancer Institute (NCI)

Terminated

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Melanoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Gastrointestinal Cancer

United States
National Cancer Institute (NCI)

Terminated

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Carcinoma, Non-Small-Cell Lung | Esophageal Neoplasms | Mesothelioma | Carcinoma, Small Cell

United States
National Cancer Institute (NCI)

Completed

Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies

Gene Transfer

United States
National Eye Institute (NEI)

Completed

Natural History and Genetic Studies of Usher Syndrome

Retinitis Pigmentosa | Usher Syndrome | Retinitis Pigmentosa Syndromic | Congenital Deafness | Retinitis Pigmentosa and Deafness

United States
National Cancer Institute (NCI)

Completed

AZD8055 for Adults With Recurrent Gliomas

Glioblastoma Multiforme | Malignant Glioma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Brainstem Glioma

United States
National Eye Institute (NEI)

Completed

Clinical and Genetic Studies in Families With Myopia and Related Diseases

Myopia

United States, China

Clinical Trials Sponsored by MICALIS Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations